BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28849054)

  • 1. Human papillomavirus E6-regulated microRNA-20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.
    Cheng Y; Geng L; Zhao L; Zuo P; Wang J
    Mol Med Rep; 2017 Oct; 16(4):5464-5470. PubMed ID: 28849054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
    Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Li X; Zhou Q; Tao L; Yu C
    Oncol Rep; 2017 Sep; 38(3):1774-1782. PubMed ID: 28731196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
    Au Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
    Ryzhakova OS; Solov'eva NI
    Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.
    Yin S; Zhang Q; Wang Y; Li S; Hu R
    Exp Ther Med; 2019 Apr; 17(4):2837-2846. PubMed ID: 30906471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
    Fan Q; Huang T; Sun X; Wang YW; Wang J; Liu Y; Ni T; Gu SL; Li YH; Wang YD
    Mol Carcinog; 2021 May; 60(5):313-330. PubMed ID: 33631046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
    Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
    Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
    Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
    Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b.
    Xu H; Li W; Luo S; Yuan J; Hao L
    Cell Signal; 2019 Oct; 62():109350. PubMed ID: 31254605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
    Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
    Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
    Liu S; Song L; Zeng S; Zhang L
    Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155.
    Chen YZ; Wang JW; Meng FC; Yang P; Zhang XG; Wu HZ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8779-8787. PubMed ID: 31696464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
    Cardeal LB; Boccardo E; Termini L; Rabachini T; Andreoli MA; di Loreto C; Longatto Filho A; Villa LL; Maria-Engler SS
    PLoS One; 2012; 7(3):e33585. PubMed ID: 22438955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
    Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
    Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.